Restenosis - An open file

Clinical Cardiology

Volumn 19, Issue 5, 1996, Pages 347-356

  Gottsauner Wolf, Michael ^a   Moliterno, David J ^a   Lincoff, A Michael ^a   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

coronary disease; percutaneous transluminal coronary angioplasty; platelet inhibitors; restenosis; stents

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOPEPTIN; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLCHICINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HEPARIN; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; MEVINOLIN; PHOTOSENSITIZING AGENT; WARFARIN;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; ELASTICITY; EXTRACELLULAR MATRIX; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; RESTENOSIS; REVIEW; STENT; THROMBOGENESIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

EID: 0029830964     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190505     Document Type: Review

References (118)

1. Hamm C, Reimers J, Ischinger T, Rupprecht H-J, Berger J, Bleifeld W, for the German Angioplasty Bypass Surgery Investigation: A randomized study of coronary angioplasty versus bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 331, 1037-1043 (1994)
2. King SB III, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao X-Q, for the Emory Angioplasty versus Surgery Trial (EAST): A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 331, 1044-1050 (1994)
3. RITA Trial Participants: Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial. Lancet 341, 573-580 (1993)
4. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Sosa Liprandi M, Palacios I: Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): In-hospital results and 1-year follow-up. J Am Coll Cardiol 22. 1060-1067 (1993)
5. Gruentzig AR, Senning A, Siegenthaler WE: Nonoperative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty. N Engl J Med 301, 61-68 (1979)
6. Bengtson JR, Mark DB, Honan MB, Rendall DS, Hinohara T, Stack RS, Hlatky MA, Califf RM, Lee KL, Pryor DB: Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Am J Cardiol 65, 28-34 (1990)
7. Hillegas WB, Ohman EM, Califf RM: Restenosis: The clinical issues. In Textbook of Interventional Cardiology (Ed. Topol EJ). W.B. Saunders, Philadelphia (1993) 415-435
8. Detre K, Holubkov R, Kelsey S, Cowley M, Kent K, Williams D, Myler R, Faxon D, Holmes D Jr, Bourassa M, Block P, Gosselin A, Bentivogli L, Leatherman L, Dorros G, King S III, Galichia J, Al-Bassam M, Leon M, Robertson T, Passamani E, the Co-Investigators of the National Heart, Lung and Blood Institute's Percutaneous Transluminal Angioplasty Registry: Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med 318, 265-270 (1988)
9. Topol EJ, Ellis SG, Cosgrove DM, Bates ER, Muller DW, Schork NJ, Schork MA, Loop FD: Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation 87, 1489-1497 (1993)
10. Paranandi SN, Topol EJ: Contemporary clinical trials of restenosis. J Inv Cardiol 6, 109-124 (1994)
11. Serruys P, de Jaegere P, Kiemeniej F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA, for the Benestent study group: A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331, 489-495 (1994)
12. Fischman DL, Leon ML, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis SG, Rake R, Goldberg S, for the Stent Restenosis Study Investigators: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331, 496-501 (1994)
13. Forrester JS, Fishbein M, Helfant R, Fagin J: A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J Am Coll Cardiol 17, 758-769 (1991)
14. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H: Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12, 616-623 (1988)
15. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG: Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. Circulation 77, 361-371 (1988)
16. Miller M, Kuntz R, Friedrich S, Leidig G, Fishman R, Schmitt S, Baim D, Safian R: Frequency and consequences of intimai hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses. Am J Cardiol 71, 652-658 (1993)
17. O'Brien E, Alpers C, Stewart D, Ferguson M, Tran N, Gordon D, Benditt E, Hinohara T, Simpson J, Schwartz S: Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 73, 223-231 (1993)
18. van Beusekom HMM, van der Giessen WJ, van Suylen RJ, Bos E, Bosman FT, Serruys PW: Histology after stenting of human saphenous vein bypass grafts: Observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 21, 45-54 (1993)
19. Rensing BJ, Hermans WRM, Beatt KJ, Laarman GJ, Suryapranata H, van den Brand M, de Feyter PJ, Serruys PW: Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty. Am J Cardiol 66, 1039-1044 (1990)
20. Rensing BJ, Hermans WR, Strauss BH, Serruys PW: Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty: A quantitative angiographic study. J Am Coll Cardiol 17, 34B-38B (1991)
21. Rensing BJ, Hermans WRM, Vos J, Beatt KJ, Bossuyt P, Rutsch W, Serruys PW, on behalf of the CARPORT Study Group: Angiographic risk factors of luminal narrowing after coronary balloon angioplasty using balloon measurements to reflect stretch and elastic recoil at the dilatation site. Am J Cardiol 69, 584-591 (1992)
22. Kaltenbach M, Beyer J, Walter S, Klepzig H, Schmidts L: Prolonged application of pressure in coronary angioplasty. Cathet Cardiovasc Diagn 10, 213-219 (1984)
23. Nissen SE, Gurley JC, Booth OC, DeMaria AN: Intravascular ultrasound of the coronary arteries: Current applications and future directions. Am J Cardiol 69, 18H-29H (1992)
24. Bourassa MG, Lesperance J, Eastwood C, Schwartz L, Cote G, Kazim F, Hudon G: Clinical, physiologic, anatomic, and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 18, 368-376 (1991)
25. Hirshfeld JW Jr, Schwartz JS, Jugo R, MacDonald RG, Goldberg S, Savage MP, Bass TA, Vetrovec G, Cowley M, Taussig AS, Whitworth HB, Margolis JR, Hill JA, Pepine CJ, the M-HEART Investigators: Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 18, 647-656 (1991)
26. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS: Generalized model of restenosis following conventional balloon angioplasty, stentins, and directional atherectomy. J Am Coll Cardiol 21, 15-25 (1993)
27. Topol EJ, Leya F. Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King SB II, Mark DB, Isner JM, Holmes DR, Ellis SG, Lee KL, Keeler GP, Berdan LG, Hinohara T, Califf RM, for the CAVEAT Study Group: A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med 329, 221-227 (1993)
28. Vandormael M, Reifart N, Preusler W, Schwarz F, Störger H, Hofmann M, Klöpper J, Müller S, Haase J: Immediate and 6 months follow-up outcomes following excimer laser angioplasty, rotational atherectomy and balloon angioplasty for complex lesions: ERBAC randomized study (abstr). Eur Heart J 15, 130 (1994)
29. Ellis SG, Bates ER, Schaible T, Weisman HF, Pin B, Topol FJ: Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent postangioplasty restenosis and thrombosis. J Am Coll Cardiol 17, 89B-95B (1991)
30. Plow EP, Ginsberg MH: Specific and saturable binding of plasma fibronectin to thrombin stimulated platelets. J Biol Chem 256, 9477-9482 (1981)
31. Plow EF, McEver RP, Coller BS, Woods VL, Marguerie GA, Ginsberg MH: Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor and thrombospondin on thrombin-stimulated human platelets. Blood 66, 724-727 (1985)
32. Plow EF, Felez J, Miles LA: Cellular regulation of fibrinolysis. Thromb Haemostas 66, 32-36 (1991)
33. Thiagarajan P, Kelly K: Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 263, 3035-3038 (1987)
34. Weiss HJ, Hawiger J, Ruggeri ZW, Turrito VT, Thiagarajan P, Hoffmannn T: Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb/IIIa complex at high shear rate. J Clin Invest 83, 288-297 (1989)
35. Fukami MH, Salganicoff L: Human platelet storage organelles. Thromb Haemosthas 38, 963-970 (1977)
36. Holmsen H: Secretable storage pools in platelets. Ann Rev Med 30, 119-134 (1979)
37. Miller DD, Boulet AJ, Tio FO, Garcia OJ, Guy DM, McEver RP, Palmaz JC, Pak KY, Neblock DS, Berger HJ, Daddona PE: In vivo rechnetium-99m S12 antibody imaging of platelet alpha-granules in rabbit endothelial neointimal proliferation after angioplasty. Circulation 83, 224-236 (1991)
38. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu Y-M, Sajer SA, Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359, 848-851 (1992)
39. Shi Y, Hutchinson HG, Hall DG, Zalewsky A: Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Circulation 88, 1190-1195 (1993)
40. Sugama Y, Malik A: Thrombin receptor 14-amino acid peptide mediates endothelial hyperadhesivity and neutrophil adhesion by P-selectin-dependent mechanism. Circ Res 71, 1015-1019 (1992)
41. Altieri D: Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion. Blood 81, 569-579 (1993)
42. Noda-Heiny H, Fujii S, Sobel B: Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Cire Res 72, 36-43 (1993)
43. Okazaki H, Majesky M, Harker L, Schwartz S: Regulation of platelet-derived growth factor ligand and receptor gene expression by x-thrombin in vascular smooth muscle cells. Circ Res 71, 1285-1293 (1992)
44. Bean KJ, Serruys PW, Luijten HE, Rensing BJ, Suryapranata H, de Feyter P, van den Brand M, Laarman GJ, Roelandt J: Restenosis after coronary angioplasty: The paradox of increased lumen diameter and restenosis. J Am Coll Cardiol 19, 258-266 (1992)
45. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K: Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 17, 433-439 (1991)
46. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR: Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 19, 267-274 (1992)
47. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA: Role of platelets in smooth muscle proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA 86, 8412-8416 (1989)
48. Schwartz RS, Holmes D Jr, Topol E: The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 20, 1284-1293 (1992)
49. Clowes AW, Reidy MA, Clowes MM: Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49, 327-333 (1983)
50. Clowes AW, Clowes MM, Reidy MA: Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle cell growth in chronically denuded vessels. Lab Invest 54, 295-303 (1986)
51. Fishman JA, Ryan GB, Karnovsky MJ: Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 32, 339-351 (1975)
52. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH: Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 15, 1667-1687 (1990)
53. Clowes AW, Schwartz SM: Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 56, 139-145 (1985)
54. Block PC, Baugham KL, Pasternak RC, Fallon JT: Transluminal angioplasty: Correlation of morphologic and angiographic findings in an experimental model. Circulation 61, 778-785 (1980)
55. LeVeen RF, Wolf GL, Villanueva TG: New rabbit atherosclerosis model for the investigation of transluminal angioplasty. Invest Radiol 17, 470-475 (1982)
56. Faxon DP, Sanborn TA, Weber VJ, Haudenschild C, Gortsman SB, McGovem WA, Ryan TJ: Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 4, 189-195 (1984)
57. Muller DWM, Ellis SG, Topol EJ: Experimental models of coronary artery restenosis. J Am Coll Cardiol 19, 418-432 (1992)
58. Lam JY, Chesebro JH, Steele PM, Heras M, Webster MW, Badimon L, Fuster V: Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs. Circulation 84, 814-820 (1991)
59. French JE, Jennings MA, Florey HW: Morphological studies on atherosclerosis in swine. Ann NY Acad Sci 127, 780-794 (1965)
60. Lindner V, Fingerle J, Reindy M: Mouse model of arterial injury. Circ Res 73, 792-796 (1993)
61. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245, 186-188 (1989)
62. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group: Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 86, 100-110 (1992)
63. Santoian E, Schneider J, Gravanis M, Foegh M, Tarazona N, Cipolla G, King S III: Angiopeptin inhibits intimai hyperplasia after angioplasty in porcine coronary arteries. Circulation 88, 11-14 (1993)
64. Kent KM, Williams DO, King SB, Broderick B, Chapekis A, Simpfendorfer C, Hinohara T, Kuntz RE, Popma JJ: Acute procedural and angiographic outcome in the angiopeptin for the prevention of restenosis after directional coronary artherectomy trial (abstr). Circulation 88, I-546 (1993)
65. Faxon DP, Sanbom TA, Haudenschild CC, Ryan TJ: Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol 53, 72C-76C (1984)
66. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS: Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 69, 721-727 (1984)
67. Currier JP, Pow TK, Minihan AC, Haudenschild CC, Faxon DP, Ryan JJ: Colchicin inhibits restenosis after iliac angioplasty in the atherosclerotic rabbit. Circulation 80(suppl2), II-66 (1989)
68. Grines CL, Rizik D, Levine A, Schreiber T, Gangadharan V, Ramos R, Choksi N, Gangadharan C, Timmis GC: Colchicine angioplasty restenosis trial (CART). Circulation 84, II-365 (1989)
69. Villa AE, Guzman LA, Weilam C, Golomb G, Levy RJ, Topol EJ: Local delivery of dexamethasone for prevention of neointimal proliferation in a the rat model of balloon angioplasty. J Clin Invest 93, 1243-1249 (1994)
70. Pepine CJ, Hirshfeld JW, MacDonald RG, Henderson MA, Bass TA, Goldberg S, Savage MP, Vetrovec G, Cowley M, Taussig AS, Whitworth HB, Margolis JR, Hill JA, Bove AA, Jugo R: A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 81, 1753-1761 (1990)
71. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR: Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318, 1714-1719 (1988)
72. Ellis SG, Roubin GS, Wilentz J, Douglas JS, King SB: Effect of 18- to 24-hour heparin administration for prevention of restenosis after complicated coronary angioplasty. Am Heart J 117, 777-782 (1989)
73. Gellman J, Ezekowitz MD, Sarembock IJ, Azrin MA, Nochomowitz LE, Lerner E, Haudenschild CC: Effect of lovastatin on intimai hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit. J Am Coll Cardiol 17, 251-259 (1991)
74. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinsky AS, King S III, Ivanhoe R, Cedarholm JC, Stillabower ME, Talley JD, DeMaio SJ, O'Neil WW, Frazier JE, Cohen-Bernstein CL, Robbins DC, Brown CL III, Alexander RW, and the Lovastatin Restenosis Trial Study Group: Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 331, 1331-1337 (1994)
75. Buchwald A, Unterberg C, Nebendahl K, Grone H, Wiegand V: Low-molecular-weight heparin reduces neointimal proliferation after coronary stent implantation in hypercholesterolemic minipigs. Circulation 86, 531-537 (1992)
76. Faxon DP, Spiro TE, Minor S, Cote G, Douglas J, Gottlieb R, Califf R, Dorosti K, Topol EJ, Gordon JB, Ohmen M: Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparine Restenosis (ERA) trial. Circulation 90, 908-914 (1994)
77. August T, Tilson M: Modification of myointimal response to arterial injury: Effects of aspirin and warfarin. Surg Forum 31, 337-338 (1980)
78. Urban P, Buller N, Fox F, Shapiro L, Bayliss J, Rickards A: Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J 60, 485-488 (1988)
79. Matsuno H, Stassen JM, Vermylen J, Deckmyn H: Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 90, 2203-2206 (1994)
80. Choi ET, Engel L, Callow AD, Sun S, Trachtenberg J, Santoro S, Ryan US: Inhibition of neointimal hyperplasia by blocking avß3 integrin with a small peptide antagonist GpenGRGDSPDCA. Vasc Surg 19, 125-134 (1994)
81. Gold H, Gimple LW, Yasuda T, Leinbach RC, Werner W, Holt R, Jordan R, Berger H, Collen D, Coller BS: Pharmacodynamic study of F(ab)2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa, in patients with unstable angina pectoris. J Clin Invest 86, 651-659 (1990)
82. Ellis SG, Naverta FI, Tscheng JT, Weisman HF, Wang AL, Pitt B, Topol EJ: Antiplatelet GP IIb/IIIa (7E3) antibody in elective PTCA: Safety and inhibition of platelet function (abstr). Circulation 82, III-191 (1990)
83. The Epic Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330, 956-961 (1994)
84. Topol EJ, Califf RM, Weissman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Western M, Sigmon K, Anderson KM, Lee KL, Willerson JT: Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 343, 881-886 (1994)
85. Roubin GS, King SB III, Douglas JS Jr: Restenosis after percutaneous transluminal coronary angioplasty: The Emory University Hospital experience. Am J Cardiol 60, 39B-43B (1987)
86. Kuntz RE, Baim D: Defining coronary restenosis: Newer clinical and angiographic paradigms. Circulation 88, 1310-1323 (1993)
87. Lehman K, Doris RJ, Feuer JM, Hall PX, Hoang DT: Paradoxical increase in restenosis rate with chronic heparin use: Final results of a randomized trial (abstr). J Am Coll Cardiol 17, 181A (1991)
88. Serruys PW, Deckers JW, Close P: A double blind, randomized, heparin controlled trial evaluating acute and longterm efficacy of r-hirudin (CGP 39393) in patients undergoing coronary angioplasty. Circulation 90, I-394 (1994)
89. Corcos T, David PR, Val PG, Renkin J, Dangiosse V, Rapold HG, Bourassa MG: Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 109, 926-931 (1985)
90. O'Keefe JH, Giorgi LV, Hartzler GO, Good TH, Ligon RW, Webb DL, McCallister BD: Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 67, 373-376 (1991)
91. Whitworth HB, Roubin GS, Hollman J, Meier B, Leimgruber PP, Douglas JS Jr, King SB III, Gruentzig AR: Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 8, 1271-1276 (1986)
92. Naftilan AJ, Pratt RE, Dzau VJ: Induction of platelet derived growth factor A chain and C-myc expression by angiotensin II in culture rat vascular smooth muscle cells. J Clin Invest 83, 1419-1424 (1989)
93. O'Keefe JHJ, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Haryzler GO: Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 19, 1597-1600 (1992)
94. Berk BC, Gordon JB, Alexander RW: Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty. J Am Coll Cardiol 17, 111B-117B (1991)
95. Stone GW, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Ligon RW, Hartzler GO: A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiorasc Diagn 18, 227-231 (1989)
96. Emanuelsson H, Bagger J-P, Balcon R, Beatt K, Foegh M, Piessens J, Popma JJ: Long-term effects of angiopeptin treatment in coronary angioplasty - reduction of clinical events but not angiographic restenosis (abstr). J Am Coll Cardiol 23, 59A (1994)
97. Dehmer GJ: Omega-3 fatty acids. In Textbook of Interventional Cardiology (Ed. Topol EJ). W.B. Saunders, Philadelphia (1993) 112-136
98. Fox PL, DiCorleto PE: Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 241, 453-456 (1988)
99. Bairati I, Roy L, Meyer F: Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 85, 950-956 (1992)
100. Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM: Reduction in the rate of early stenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 319, 733-740 (1988)
101. Milner MR, Gallino RA, Leffingwell A, Pichard AD, Brooks-Robinson S, Rosenberg J, Little T, Lindsay JJ: Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 64, 294-299 (1989)
102. Nye ER, Ablett MB, Robertson MC, Ilsley CD, Sutherland WH: Effect on eicosapentaeonic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust N Z J Med 20, 549-552 (1990)
103. Slack JD, Pinkerton CA, van Tassel J, Orr CM, Scott M, Allen B, Nasser WK: Can oral fish oil supplement minimize restenosis after percutaneous transluminal coronary angioplasty? (abstr). J Am Coll Cardiol 9, 64A (1987)
104. Leaf A, Jorgensen MB, Jacobs AK, Cote G, Schoenfeld DA, Scheer J, Weiner BH, Slack JD, Kellet MA, Raizner AE, Weber PC, Mahrer PR, Rossouw JE: Does fish oil prevent restenosis after coronary angioplasty? Circulation 90, 2248-2257 (1994)
105. Cairns JA, Gill JB, Morton B, Roberts R, Gent M, Hirsh J: Enoxaparine and Maxepa for the prevention of Angioplasty Restenosis (EMPAR) (abstr). Circulation 90, I-651 (1994)
106. Constantinescu DE, Banka VS, Tulenko TN: Lovastatin inhibits proliferation of arterial smooth muscle and endothelial cells. Indication in atherosclerosis and prevention of restenosis (abstr). Eur Heart J 13, 82 (1992)
107. Okamoto S, Inden M, Setsuda M, Konishi T, Nakano T: Effects of trapidil (triazolopyrimidine). a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 123, 1439-1444 (1992)
108. The Multicenter Italian Research Trial with Trapidil in the Prevention of Restenosis after PTCA (STARC): Trapidil (platelet derived growth factor inhibitor) prevents restenosis after PTCA: Results of the STARC study (abstr). Circulation 88, I-595 (1993)
109. Simons M, Edelman E, DeKeyser J-L, Langer R, Rosenberg R: Antisense c-myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature 359, 67-70 (1992)
110. Shi Y, Fard A, Vermani P, Zalewski A: C-myc antisense oligomers reduce neointima formation in the porcine coronary arteries (abstr). J Am Coll Cardiol 23, 395A (1994)
111. Simons M, Edelman ER, Rosenberg RD: Inhibition of neointimal formation by anti-PCNA oligonucleotides in a rat model of arterial injury (abstr). Circulation 88, I-368 (1993)
112. Epstein S, Speir E, Finkel T: Do antisense approaches to the problem of restenosis make sense. Circulation 88, 1351-1353 (1993)
113. Gonschior P, Fleuchaus M, Gerheuser F, Mack B, Höfling B: Local drug delivery and photodynamic therapy (PDT) in an experimental restenosis model (abstr). J Am Coll Cardiol 23, 473A (1994)
114. Gregory KW, Buckley LA, Haw TE, Grunkemeier JM, Chasteney EA, Qu Z, Tuke-Bahlman D, Fahrenbach H, Block PC: Photochemotherapy using psoralen and UVA light in a porcine model of intima hyperplasia (abstr). Circulation 88, I-82 (1993)
115. Speedy TJ, March KL, Wilensky RL, Aita M, Gradus-Pizlo I, Hathaway DR: The combination of 8-methoxypsoralen and ultraviolet A light in vivo inhibits smooth muscle proliferation after angioplasty (abstr). Circulation 88, I-81 (1993)
116. US Directional Atherectomy Investigators Group: Restenosis following directional coronary atherectomy in a multicenter experience (abstr). Circulation 82, III-679 (1990)
117. Adelman AG, Cohen EA, Kimball BP, Bonan R, Ricci DR, Webb JG, Laramee L, Barbeau G, Traboulsi M, Corbett BN, Schwartz L, Logan AG: A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 329, 228-233 (1993)
118. Serruys PW, Breeman A: Coronary angioplasty - long-term follow-up results and detection of restenosis: Guidelines for aviation cardiology. A European view. Eur Heart J 13, 17H-88H (1992)